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Community pharmacies for detection and
control of hypertension
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The Health Survey for England shows us that 37%
of the adult population are hypertensive (140/90
mm Hg or on treatment for hypertension).1 Just over
a quarter of these people are on antihypertensive
therapy, and of these, only 28% have their blood
pressure controlled at less than 140/90 mm Hg.
Thus, the old ‘rule of halves’ has become a ‘rule of
quarters’ if contemporary guidelines on blood press-
ure control are followed.2,3 Similarly poor adherence
to blood pressure targets has been shown in equival-
ent studies in the US.4
There are many potential reasons for this poor
control. Hypertension is largely asymptomatic with
little biological feedback to patients in terms of
blood pressure control.5 Treatment is generally life-
long and may be associated with dose-related side
effects. Around half of hypertensive patients discon-
tinue new prescriptions for antihypertensive drugs
in the first 6 months.6
It is not simply a question of motivating patients.
Research in UK general practice has shown a lack of
professional action in the presence of high recorded
blood pressures along with a reluctance to prescribe
for isolated systolic hypertension.7 This is despite
good evidence that the absolute benefit of treatment
of isolated systolic hypertension is greater than for
mild–moderate hypertension in middle-aged
patients.8 Fear of causing side effects may be the rea-
son for this inaction although modern treatment
trials have shown relatively modest levels of side
effects.9
Workload in primary care has been cited as
another reason for poor performance and as a bar-
rier to further change. It has been estimated that
each GP has around 272 adult patients on his or
her list that require treatment according to the BHS
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guidelines.10 Hypertension may not be a priority
for GPs as they attempt to cope with increasing
demand for appointments and pressure to reduce
waiting times.11
Therefore, the answer is not to expect current ser-
vices to stretch further, but rather, to explore novel
methods for the detection and management of high
blood pressure. Methods that have been tried
include: public health screening ‘fairs’ in housing
blocks and shopping centres, work-place screening,
case finding in other primary care settings, such as
opticians and dental surgeries, and self-monitoring
of blood pressure.12
Unfortunately, evidence for the effectiveness of
any of these approaches is weak.12 Another
approach of potential promise that is explored by
Earle et al13 in this issue of Journal of Human
Hypertension is making use of community phar-
macies.
Community pharmacies are often sited alongside
surgeries and are a largely untapped resource for
improved patient care. Studies in the US have
shown that pharmacist involvement in the manage-
ment of chronic diseases such as hypertension can
be effective.14 In 1981, a study in nine pharmacies in
Birmingham showed that screening for high blood
pressure was feasible although only 215 patients
availed themselves of the service in a 5-month per-
iod.15 Referrals to primary care for consideration of
treatment were low (10/215, 5%) although this was
largely due to the high thresholds used (eg,
160/110 was considered normotensive for the over
60s). A questionnaire to participants showed high
levels of support for the service. In 1990 a study
from Nottingham examined the provision of free
blood pressure checks to middle-aged patients
attending an inner city pharmacy over a period of 6
weeks. Few of the readings appeared to have been
relayed to their general practitioner and the GPs
involved were generally unenthusiastic.16 Little pro-
gress has been made in the 10 years that have
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elapsed, perhaps due to a lack of funding for this
type of venture. Unified budgets at the level of Pri-
mary Care Trusts may provide greater impetus for
such schemes.
Earle et al13 looked at the feasibility of offering
blood pressure measurement in six pharmacies in
North London. Volunteers were recruited via
advertisements in local media and the pharmacies
themselves and had blood pressure measured
using validated automated electronic sphygmo-
manometers. Measurements were accompanied by
a personalised management plan produced cen-
trally using decision support software. A total of
263 patients used the service over 16 weeks and it
appears to have been safe in that all those advised
to attend their GPs with uncontrolled blood press-
ure did. Patients from ethnic minorities were as
likely to register for the scheme as white subjects
although the numbers involved were small. Per-
haps not surprisingly, the service appears to have
been used preferentially by those with pre-existing
hypertension who presumably were more likely to
see the service advertised during routine visits to
collect medication.
Having demonstrated feasibility, further work is
now required to ascertain the effect on outcome of
this type of scheme. The algorithm used will require
modification to allow appropriate action in terms of
medication adjustment in response to pressures over
target in known hypertensives. The advent of the
universal electronic patient record (if it ever arrives)
would allow the possibility of automatic insertion of
blood pressure readings from multiple sources into
patient notes.
Does the public want more involvement in its own
care? Evidence is accumulating that it does.17 A
study looking at thresholds for starting treatment for
hypertension showed that members of the general
public considered initiation of treatment to be
appropriate at lower levels of risk than either GPs
or hospital physicians.18 Providing people with the
means to monitor their own pressures, such as
through open-access to sphygmomanometers in
community pharmacies, is one way in which greater
involvement could be achieved.
If the new ‘rule of quarters’ is to be tackled,
approaches such as that described by Earle et al13
need to be considered. Responsibility for control of
blood pressure can be shared amongst community-
based health care professionals, and the potential for
giving patients a more central role explored. There
have been major advances in the evidence base for
the treatment of hypertension in the last decade.
Implementation (and research on implementation)
is now the priority.
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